PGIM India Mutual FundEquity Scheme - Multi Cap Fund2.1 years
The scheme seek to generate long term capital appreciation by investing in a portfolio of equity and equity related securities across large cap, mid cap and small cap stocks.
Buying brief
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 29 Oct 2026
Stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
In three lines
Fits if · The fund beat the category median in 83% of rolling 1-year windows.
Prefer peers if · Prefer LIC MF Multi Cap Fund if you want a same-category peer with stronger evidence.
Buy checklist
History depth
Fail
2.1 years - thin for judging consistency.
Engine status
Watch
Recent evidence is mixed. Compare peers before increasing exposure.
Expense ratio
Pass
0.78% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -18.1%. Ask whether you can hold through a similar fall.
Vs category
n/a
Category relative read still thin.
Manager tenure
Pass
Anandha Padmanabhan Anjeneyan · 2.2 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 28.3% of the portfolio.
Same-category peers are preloaded into compare when available.
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 18%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
Monitor is recent mixed evidence - keep the SIP unless the buying brief says prefer peers, then swap with intent.
NAV
Path not in current snapshots
n/a
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Peak to trough from a running NAV high, with the path and recovery episodes.
Drawdown
Path not in current snapshots
n/a
26 Sept 2024 – 16 Sept 2025
Trough 28 Feb 2025 · recovered in 200 days
-18.1%
29 Oct 2025 – 17 Jun 2026
Trough 23 Mar 2026 · recovered in 86 days
-13.5%
26 Aug 2026 – open
Trough 23 Oct 2026 · not recovered
-9.0%
19 Sept 2025 – 16 Oct 2025
Trough 30 Sept 2025 · recovered in 16 days
-4.3%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
24
Vs category
58
Consistency
83
Risk-adjusted
15
Drawdown
55
Mean
47
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Buying stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
Why this status
Supporting reads
30 Sept 2026 · 101 holdings · top 10 are 28.3%.
Others CBLO
Unspecified
5.2%
ICICI Bank Ltd
Financial
4.4%
HDFC Bank Ltd
Financial
3.8%
INDO-MIM Ltd.
Industrials
2.8%
Reliance Industries Ltd
Energy & Utilities
2.3%
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
27 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
26 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
23 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
22 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
21 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
19 Oct 2026
DECISION
Status moved from HEALTHY to MONITOR.
15 Sept 2026
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
LIC Mutual Fund
Caveat: Deeper drawdown
Trust Mutual Fund
Caveat: Higher volatility · Higher TER
Union Mutual Fund
Caveat: Deeper drawdown · Higher TER
Bajaj Finserv Mutual Fund
Caveat: Higher TER
SBI Mutual Fund
Caveat: Higher TER
PGIM India Mutual FundEquity Scheme - Multi Cap Fund2.1 years
The scheme seek to generate long term capital appreciation by investing in a portfolio of equity and equity related securities across large cap, mid cap and small cap stocks.
Buying brief
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 29 Oct 2026
Stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
In three lines
Fits if · The fund beat the category median in 83% of rolling 1-year windows.
Prefer peers if · Prefer LIC MF Multi Cap Fund if you want a same-category peer with stronger evidence.
Buy checklist
History depth
Fail
2.1 years - thin for judging consistency.
Engine status
Watch
Recent evidence is mixed. Compare peers before increasing exposure.
Expense ratio
Pass
0.78% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -18.1%. Ask whether you can hold through a similar fall.
Vs category
n/a
Category relative read still thin.
Manager tenure
Pass
Anandha Padmanabhan Anjeneyan · 2.2 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 28.3% of the portfolio.
Same-category peers are preloaded into compare when available.
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 18%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
Monitor is recent mixed evidence - keep the SIP unless the buying brief says prefer peers, then swap with intent.
NAV
29 Oct 2026 · +0.9% over 1Y
10.51
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Peak to trough from a running NAV high, with the path and recovery episodes.
Drawdown
29 Oct 2026
-6.1%
26 Sept 2024 – 16 Sept 2025
Trough 28 Feb 2025 · recovered in 200 days
-18.1%
29 Oct 2025 – 17 Jun 2026
Trough 23 Mar 2026 · recovered in 86 days
-13.5%
26 Aug 2026 – open
Trough 23 Oct 2026 · not recovered
-9.0%
19 Sept 2025 – 16 Oct 2025
Trough 30 Sept 2025 · recovered in 16 days
-4.3%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
24
Vs category
58
Consistency
83
Risk-adjusted
15
Drawdown
55
Mean
47
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Buying stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
Why this status
Supporting reads
30 Sept 2026 · 101 holdings · top 10 are 28.3%.
Others CBLO
Unspecified
5.2%
ICICI Bank Ltd
Financial
4.4%
HDFC Bank Ltd
Financial
3.8%
INDO-MIM Ltd.
Industrials
2.8%
Reliance Industries Ltd
Energy & Utilities
2.3%
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
27 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
26 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
23 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
22 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
21 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
19 Oct 2026
DECISION
Status moved from HEALTHY to MONITOR.
15 Sept 2026